171 related articles for article (PubMed ID: 34203724)
21. Concomitant targeting of Hedgehog signaling and MCL-1 synergistically induces cell death in Hedgehog-driven cancer cells.
Meister MT; Boedicker C; Linder B; Kögel D; Klingebiel T; Fulda S
Cancer Lett; 2019 Nov; 465():1-11. PubMed ID: 31465840
[TBL] [Abstract][Full Text] [Related]
22. EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition.
Zucal C; D'Agostino VG; Casini A; Mantelli B; Thongon N; Soncini D; Caffa I; Cea M; Ballestrero A; Quattrone A; Indraccolo S; Nencioni A; Provenzani A
BMC Cancer; 2015 Nov; 15():855. PubMed ID: 26542945
[TBL] [Abstract][Full Text] [Related]
23. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M
Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075
[TBL] [Abstract][Full Text] [Related]
24. Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity.
Lau BW; Huh K; Madero-Marroquin R; De Marchi F; Lim Y; Wang Q; Lobo F; Marchionni L; Smith DB; DeZern A; Levis MJ; Aplan PD; Matsui W; Gondek LP
Oncogene; 2019 Jan; 38(5):687-698. PubMed ID: 30171262
[TBL] [Abstract][Full Text] [Related]
25. Garcinone C suppresses colon tumorigenesis through the Gli1-dependent hedgehog signaling pathway.
Chen J; Qiu S; Kim JT; Cho JS; Moon JH; Zhou Y; Auh JH; Lee HJ
Phytomedicine; 2020 Dec; 79():153334. PubMed ID: 32920288
[TBL] [Abstract][Full Text] [Related]
26. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism.
Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG
Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254
[TBL] [Abstract][Full Text] [Related]
27. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
28. AMP-activated protein kinase mediates T cell activation-induced expression of FasL and COX-2 via protein kinase C theta-dependent pathway in human Jurkat T leukemia cells.
Lee JY; Choi AY; Oh YT; Choe W; Yeo EJ; Ha J; Kang I
Cell Signal; 2012 Jun; 24(6):1195-207. PubMed ID: 22330070
[TBL] [Abstract][Full Text] [Related]
29. The transcriptional activity of Gli1 is negatively regulated by AMPK through Hedgehog partial agonism in hepatocellular carcinoma.
Xu Q; Liu X; Zheng X; Yao Y; Wang M; Liu Q
Int J Mol Med; 2014 Sep; 34(3):733-41. PubMed ID: 25017332
[TBL] [Abstract][Full Text] [Related]
30. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clusters.
Chandra V; Das T; Gulati P; Biswas NK; Rote S; Chatterjee U; Ghosh SN; Deb S; Saha SK; Chowdhury AK; Ghosh S; Rudin CM; Mukherjee A; Basu A; Dhara S
PLoS One; 2015; 10(3):e0116390. PubMed ID: 25775002
[TBL] [Abstract][Full Text] [Related]
32. GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.
Geng L; Lu K; Li P; Li X; Zhou X; Li Y; Wang X
Oncotarget; 2017 Jul; 8(30):48701-48710. PubMed ID: 27275540
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
Graab U; Hahn H; Fulda S
Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378
[TBL] [Abstract][Full Text] [Related]
34. AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.
Grimaldi C; Chiarini F; Tabellini G; Ricci F; Tazzari PL; Battistelli M; Falcieri E; Bortul R; Melchionda F; Iacobucci I; Pagliaro P; Martinelli G; Pession A; Barata JT; McCubrey JA; Martelli AM
Leukemia; 2012 Jan; 26(1):91-100. PubMed ID: 21968881
[TBL] [Abstract][Full Text] [Related]
35. Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor Cells.
Long B; Wang LX; Zheng FM; Lai SP; Xu DR; Hu Y; Lin DJ; Zhang XZ; Dong L; Long ZJ; Tong XZ; Liu Q
Cell Physiol Biochem; 2016; 38(4):1288-302. PubMed ID: 27008269
[TBL] [Abstract][Full Text] [Related]
36. Antagonistic control of muscle cell size by AMPK and mTORC1.
Mounier R; Lantier L; Leclerc J; Sotiropoulos A; Foretz M; Viollet B
Cell Cycle; 2011 Aug; 10(16):2640-6. PubMed ID: 21799304
[TBL] [Abstract][Full Text] [Related]
37. Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL.
Decker S; Zirlik K; Djebatchie L; Hartmann D; Ihorst G; Schmitt-Graeff A; Herchenbach D; Jumaa H; Warmuth M; Veelken H; Dierks C
Blood; 2012 Jan; 119(4):997-1007. PubMed ID: 22130798
[TBL] [Abstract][Full Text] [Related]
38. Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications.
Grund-Gröschke S; Stockmaier G; Aberger F
Cell Commun Signal; 2019 Dec; 17(1):172. PubMed ID: 31878932
[TBL] [Abstract][Full Text] [Related]
39. Dual degradation signals destruct GLI1: AMPK inhibits GLI1 through β-TrCP-mediated proteasome degradation.
Zhang R; Huang SY; Ka-Wai Li K; Li YH; Hsu WH; Zhang GJ; Chang CJ; Yang JY
Oncotarget; 2017 Jul; 8(30):49869-49881. PubMed ID: 28562331
[TBL] [Abstract][Full Text] [Related]
40. MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.
Lu J; Liu L; Zheng M; Li X; Wu A; Wu Q; Liao C; Zou J; Song H
Oncogene; 2018 Jul; 37(28):3864-3878. PubMed ID: 29662197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]